Neuralink Expands Brain Chip Trials to Canada, Targets Revolutionary Treatments

Elon Musk’s Neuralink has begun brain chip trials in Canada, marking a significant milestone in neurotechnology. Kevin Smith, CEO of Canada’s University Health Network, expressed pride in advancing neurosurgery research, as the company continues recruiting patients in the US, UK, and Canada.

Neuralink’s pioneering device aims to enable patients to control external devices, like computers, using their thoughts. The company is also exploring applications for treating conditions such as blindness, signaling a transformative step toward integrating technology with human cognition and healing.